We are live on ! Find out more
SUPN icon

Supernus Pharmaceuticals
SUPN

312 hedge funds and large institutions have $2.34B invested in Supernus Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 106 increasing their positions, 115 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

56% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 36

18% more capital invested

Capital invested by funds: $1.98B → $2.34B (+$360M)

5% more funds holding

Funds holding: 297 → 312 (+15)

2.45% more ownership

Funds ownership: 96.94% → 99.38% (+2.4%)

8% less repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 115

32% less call options, than puts

Call options by funds: $5.1M | Put options by funds: $7.53M

Holders
312
Holders Change
+15
Holders Change %
+5.05%
% of All Funds
7.15%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.11%
New
56
Increased
106
Reduced
115
Closed
36
Calls
$5.1M
Puts
$7.53M
Net Calls
-$2.43M
Net Calls Change
-$111K

Top Buyers

Rank Fund Capital Flow
1
PIM
Provident Investment Management
Michigan
+$22.5M
2
CRCP
Copper Rock Capital Partners
Massachusetts
+$22.3M
3
JP Morgan Chase
JP Morgan Chase
New York
+$12M
4
Renaissance Technologies
Renaissance Technologies
New York
+$11.6M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$8.47M

Top Sellers

Rank Fund Capital Flow
1
EA
Emerald Advisers
Pennsylvania
-$22M
2
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$18.2M
3
SI
Scout Investments
Missouri
-$17.4M
4
GIP
Granite Investment Partners
California
-$13.5M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$5.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
101
Royce & Associates
New York
$3.07M -$1.34M -32,000 -32%
Canada Life
102
Canada Life
Manitoba, Canada
$3.06M -$5.84K -140 -0.2%
SDIC
103
South Dakota Investment Council
South Dakota
$3M +$2.74M +65,600 New
Skandinaviska Enskilda Banken (SEB)
104
Skandinaviska Enskilda Banken (SEB)
Sweden
$2.95M -$609K -14,600 -18%
GCP
105
GSA Capital Partners
United Kingdom
$2.85M -$209K -5,000 -7%
EIM
106
Essex Investment Management
Massachusetts
$2.82M -$146K -3,508 -5%
ECM
107
Element Capital Management
New York
$2.82M +$2.57M +61,534 New
Comerica Bank
108
Comerica Bank
Texas
$2.64M +$52.6K +1,261 +2%
SGAM
109
Smith Group Asset Management
Texas
$2.64M +$501K +12,009 +26%
TCM
110
Timpani Capital Management
Wisconsin
$2.63M +$530K +12,702 +28%
VOYA Investment Management
111
VOYA Investment Management
Georgia
$2.59M – – –
DIA
112
Dana Investment Advisors
Wisconsin
$2.59M -$33.3K -798 -1%
Squarepoint
113
Squarepoint
New York
$2.59M +$1.97M +47,122 +499%
Rafferty Asset Management
114
Rafferty Asset Management
New York
$2.59M +$2.36M +56,529 New
HI
115
HBK Investments
Texas
$2.55M +$702K +16,816 +43%
California Public Employees Retirement System
116
California Public Employees Retirement System
California
$2.38M -$297K -7,108 -12%
AI
117
Axiom Investors
Connecticut
$2.37M -$210K -5,030 -9%
HSBC Holdings
118
HSBC Holdings
United Kingdom
$2.36M +$2.15M +51,590 New
UCFA
119
United Capital Financial Advisors
Texas
$2.34M +$22.3K +535 +1%
HSA
120
Hussman Strategic Advisors
Maryland
$2.29M +$2.09M +50,000 New
SAM
121
Shell Asset Management
Netherlands
$2.28M – – –
BCC
122
Bridge City Capital
Oregon
$2.26M +$125K +2,995 +6%
QIM
123
Quantitative Investment Management
Virginia
$2.21M +$2.01M +48,200 New
State of Wisconsin Investment Board
124
State of Wisconsin Investment Board
Wisconsin
$2.17M – – –
Fidelity Investments
125
Fidelity Investments
Massachusetts
$2.15M -$282K -6,759 -13%
3 4
5
6 7

SUPN Hedge Fund Activity: Q1 2018 in Review

312 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Supernus Pharmaceuticals (SUPN) for Q1 2018, worth a combined $2.34B — up 18% from $1.98B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new SUPN positions and 36 closed out — a net gain of 20 holders — while 106 added to existing stakes and 115 trimmed.

The largest buyer was Provident Investment Management, opening a new position worth an estimated $22.5M. The largest seller was Emerald Advisers, exiting entirely with an estimated $22M sold.

  • 312 institutional investors held Supernus Pharmaceuticals (SUPN) as of Q1 2018, up from 297 in Q4 2017.
  • Funds reported $2.34B of Supernus Pharmaceuticals stock for Q1 2018, up 18% quarter-over-quarter.
  • 56 funds opened new Supernus Pharmaceuticals positions in Q1 2018 and 36 closed out, a net change of +20 holders.
  • The largest Supernus Pharmaceuticals buyer in Q1 2018 was Provident Investment Management, an estimated $22.5M added.
  • The largest Supernus Pharmaceuticals seller in Q1 2018 was Emerald Advisers, an estimated $22M sold.

Based on aggregated 13F filings for Q1 2018.